Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers I Landa, T Ibrahimpasic, L Boucai, R Sinha, JA Knauf, RH Shah, S Dogan, ... The Journal of clinical investigation 126 (3), 1052-1066, 2016 | 1188 | 2016 |
Cancer therapy shapes the fitness landscape of clonal hematopoiesis KL Bolton, RN Ptashkin, T Gao, L Braunstein, SM Devlin, D Kelly, M Patel, ... Nature genetics 52 (11), 1219-1226, 2020 | 559 | 2020 |
Natural history and tumor volume kinetics of papillary thyroid cancers during active surveillance RM Tuttle, JA Fagin, G Minkowitz, RJ Wong, B Roman, S Patel, B Untch, ... JAMA Otolaryngology–Head & Neck Surgery 143 (10), 1015-1020, 2017 | 479 | 2017 |
Age-and race-based serum thyrotropin reference limits MI Surks, L Boucai The Journal of Clinical Endocrinology & Metabolism 95 (2), 496-502, 2010 | 331 | 2010 |
An approach for development of age-, gender-, and ethnicity-specific thyrotropin reference limits L Boucai, JG Hollowell, MI Surks Thyroid 21 (1), 5-11, 2011 | 320 | 2011 |
Association of thyroid function test abnormalities and thyroid autoimmunity with preterm birth: a systematic review and meta-analysis TIM Korevaar, A Derakhshan, PN Taylor, M Meima, L Chen, S Bliddal, ... Jama 322 (7), 632-641, 2019 | 292 | 2019 |
Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers LA Dunn, EJ Sherman, SS Baxi, V Tchekmedyian, RK Grewal, SM Larson, ... The Journal of Clinical Endocrinology & Metabolism 104 (5), 1417-1428, 2019 | 233 | 2019 |
Hypoglycemia-associated mortality is not drug-associated but linked to comorbidities L Boucai, WN Southern, J Zonszein The American journal of medicine 124 (11), 1028-1035, 2011 | 228 | 2011 |
Association of maternal thyroid function with birthweight: a systematic review and individual-participant data meta-analysis A Derakhshan, RP Peeters, PN Taylor, S Bliddal, DM Carty, M Meems, ... The lancet Diabetes & endocrinology 8 (6), 501-510, 2020 | 217 | 2020 |
Reference limits of serum TSH and free T4 are significantly influenced by race and age in an urban outpatient medical practice L Boucai, MI Surks Clinical endocrinology 70 (5), 788-793, 2009 | 189 | 2009 |
Thyrotropin suppression increases the risk of osteoporosis without decreasing recurrence in ATA low-and intermediate-risk patients with differentiated thyroid carcinoma LY Wang, AW Smith, FL Palmer, RM Tuttle, A Mahrous, IJ Nixon, SG Patel, ... Thyroid 25 (3), 300-307, 2015 | 178 | 2015 |
Thyroid cancer: a review L Boucai, M Zafereo, ME Cabanillas Jama 331 (5), 425-435, 2024 | 164 | 2024 |
Association between maternal thyroid function and risk of gestational hypertension and pre-eclampsia: a systematic review and individual-participant data meta-analysis FJK Toloza, A Derakhshan, T Männistö, S Bliddal, PV Popova, DM Carty, ... The Lancet Diabetes & Endocrinology 10 (4), 243-252, 2022 | 123 | 2022 |
Activation of KATP channels suppresses glucose production in humans P Kishore, L Boucai, K Zhang, W Li, S Koppaka, S Kehlenbrink, ... The Journal of clinical investigation 121 (12), 4916-4920, 2011 | 123 | 2011 |
Effect of age on response to therapy and mortality in patients with thyroid cancer at high risk of recurrence S Shah, L Boucai The Journal of Clinical Endocrinology & Metabolism 103 (2), 689-697, 2018 | 70 | 2018 |
Impact of hypoglycemia in hospitalized patients M Carey, L Boucai, J Zonszein Current diabetes reports 13, 107-113, 2013 | 58 | 2013 |
Active surveillance of papillary thyroid cancer: frequency and time course of the six most common tumor volume kinetic patterns RM Tuttle, J Fagin, G Minkowitz, R Wong, B Roman, S Patel, B Untch, ... Thyroid 32 (11), 1337-1345, 2022 | 50 | 2022 |
Radioactive iodine–related clonal hematopoiesis in thyroid cancer is common and associated with decreased survival L Boucai, J Falcone, J Ukena, CC Coombs, A Zehir, R Ptashkin, ... The Journal of Clinical Endocrinology & Metabolism 103 (11), 4216-4223, 2018 | 47 | 2018 |
Early pregnancy thyroid hormone reference ranges in Chilean women: The influence of body mass index L Mosso, A Martínez, MP Rojas, G Latorre, P Margozzini, T Lyng, ... Clinical endocrinology 85 (6), 942-948, 2016 | 47 | 2016 |
Enhancing Radioiodine Incorporation in BRAF-Mutant, Radioiodine-Refractory Thyroid Cancers with Vemurafenib and the Anti-ErbB3 Monoclonal Antibody CDX … V Tchekmedyian, L Dunn, E Sherman, SS Baxi, RK Grewal, SM Larson, ... Thyroid 32 (3), 273-282, 2022 | 46 | 2022 |